These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26048187)

  • 41. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates.
    Rapeli P; Fabritius C; Kalska H; Alho H
    BMC Clin Pharmacol; 2011 Aug; 11():13. PubMed ID: 21854644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort.
    Harris A; Selling D; Luther C; Hershberger J; Brittain J; Dickman S; Glick A; Lee JD
    Subst Abus; 2012; 33(1):70-5. PubMed ID: 22263715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.
    Larance B; Degenhardt L; O'Brien S; Lintzeris N; Winstock A; Mattick RP; Bell J; Ali R
    Drug Alcohol Rev; 2011 Nov; 30(6):613-20. PubMed ID: 21355939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
    Petersen H; Skauge L; Svejsø J; Ege PP
    Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Breast feeding during methadon- and buprenorphin therapy].
    Müller MJ; Lange M; Paul T; Seeliger S
    Klin Padiatr; 2011 Dec; 223(7):408-13. PubMed ID: 21969026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Better efficacy of buprenorphine and methadone in opioid dependence. Requirements for abstinence from non-opioids before starting treatment paid off].
    Hoffmann O; Frisell F; Ljungberg T
    Lakartidningen; 2014 Jan 29-Feb 4; 111(5):147-9. PubMed ID: 24624763
    [No Abstract]   [Full Text] [Related]  

  • 49. Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphine.
    Naren T; Cook J; MacCartney P; Membrey D
    Drug Alcohol Rev; 2024 May; 43(4):1013-1018. PubMed ID: 38408741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.
    Moratti E; Kashanpour H; Lombardelli T; Maisto M
    Clin Drug Investig; 2010; 30 Suppl 1():3-11. PubMed ID: 20450240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diversion and injection of a buprenorphine-naloxone soluble film formulation.
    Larance B; Lintzeris N; Ali R; Dietze P; Mattick R; Jenkinson R; White N; Degenhardt L
    Drug Alcohol Depend; 2014 Mar; 136():21-7. PubMed ID: 24461476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medically assisted treatment for opiate addiction--suboxone method as prevention of social exclusion of youth--Tuzla model.
    Hasanović M; Pajević I; Kuldija A; Delić A
    Psychiatr Danub; 2012 Oct; 24 Suppl 3():S398-404. PubMed ID: 23114824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
    Johnson RE; Chutuape MA; Strain EC; Walsh SL; Stitzer ML; Bigelow GE
    N Engl J Med; 2000 Nov; 343(18):1290-7. PubMed ID: 11058673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers.
    Mintzer MZ; Correia CJ; Strain EC
    Drug Alcohol Depend; 2004 May; 74(2):205-9. PubMed ID: 15099664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Management of opioid maintenance treatments when analgesic treatments are required].
    Laprevote V; Geoffroy PA; Rolland B; Leheup BF; Di Patrizio P; Cottencin O; Schwan R
    Presse Med; 2013; 42(7-8):1085-90. PubMed ID: 23518339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors.
    Johnson B; Richert T
    Int J Drug Policy; 2015 Feb; 26(2):183-90. PubMed ID: 25465344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series.
    Klaire S; Zivanovic R; Barbic SP; Sandhu R; Mathew N; Azar P
    Am J Addict; 2019 Jul; 28(4):262-265. PubMed ID: 30901127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome evaluation of the opioid agonist maintenance treatment in Iran.
    Esmaeili HR; Ziaddinni H; Nikravesh MR; Baneshi MR; Nakhaee N
    Drug Alcohol Rev; 2014 Mar; 33(2):186-93. PubMed ID: 24428135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.